Endra Life Sciences Stock Buy Hold or Sell Recommendation
| NDRA Stock | USD 4.69 0.04 0.86% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding ENDRA Life Sciences is 'Strong Sell'. Macroaxis provides ENDRA Life buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding NDRA positions.
Check out ENDRA Life Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as ENDRA and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards ENDRA Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
ENDRA |
Execute ENDRA Life Buy or Sell Advice
The ENDRA recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on ENDRA Life Sciences. Macroaxis does not own or have any residual interests in ENDRA Life Sciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute ENDRA Life's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
ENDRA Life Trading Alerts and Improvement Suggestions
| ENDRA Life Sciences generated a negative expected return over the last 90 days | |
| ENDRA Life Sciences has high historical volatility and very poor performance | |
| ENDRA Life Sciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (10.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ENDRA Life Sciences currently holds about 11.28 M in cash with (9.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18. | |
| ENDRA Life Sciences has a poor financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Disposition of tradable shares by Francois Michelon of ENDRA Life at 0.87 subject to Rule 16b-3 |
ENDRA Life Returns Distribution Density
The distribution of ENDRA Life's historical returns is an attempt to chart the uncertainty of ENDRA Life's future price movements. The chart of the probability distribution of ENDRA Life daily returns describes the distribution of returns around its average expected value. We use ENDRA Life Sciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of ENDRA Life returns is essential to provide solid investment advice for ENDRA Life.
| Mean Return | 0.13 | Value At Risk | -7.76 | Potential Upside | 8.45 | Standard Deviation | 5.39 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of ENDRA Life historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
ENDRA Stock Institutional Investors
| Shares | Xtx Topco Ltd | 2024-09-30 | 0.0 | Hrt Financial Llc | 2024-09-30 | 0.0 | Ubs Group Ag | 2024-12-31 | 95.0 | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 13.0 | Bank Of America Corp | 2024-12-31 | 4.0 | Susquehanna International Group, Llp | 2024-09-30 | 0.0 | Sassicaia Capital Advisers Llc | 2024-09-30 | 0.0 | Jane Street Group Llc | 2024-09-30 | 0.0 | Goss Wealth Management Llc | 2024-09-30 | 0.0 | Northern Trust Investments N A | 2024-12-31 | 0.0 | Vanguard Group Inc | 2024-09-30 | 0.0 |
ENDRA Life Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (476.2K) | (695.0K) | (1.4M) | 138.0K | 124.2K | 130.5K | |
| Change In Cash | 1.1M | 2.2M | (4.6M) | (2.1M) | (1.8M) | (1.8M) | |
| Free Cash Flow | (10.8M) | (11.2M) | (13.0M) | (9.6M) | (8.6M) | (9.1M) | |
| Depreciation | 165.2K | 224.4K | 234.3K | 275.5K | 316.8K | 332.6K | |
| Other Non Cash Items | 2.3M | (298.7K) | 1.4K | 162.9K | 146.6K | 139.3K | |
| Capital Expenditures | 51.3K | 45K | 202.6K | 33.9K | 30.5K | 29.0K | |
| Net Income | (11.7M) | (11.2M) | (13.2M) | (10.1M) | (9.1M) | (9.5M) | |
| End Period Cash Flow | 7.2M | 9.5M | 4.9M | 2.8M | 3.3M | 4.7M | |
| Change To Netincome | 1.6M | 2.1M | 1.1M | 1.2M | 1.4M | 1.3M | |
| Investments | (75.3K) | (45K) | (202.6K) | (65.6K) | (59.0K) | (62.0K) | |
| Dividends Paid | 395.6K | 121.1K | 7.8K | 840.0 | 756.0 | 718.2 |
ENDRA Life Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ENDRA Life or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ENDRA Life's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ENDRA stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.13 | |
β | Beta against Dow Jones | 1.03 | |
σ | Overall volatility | 5.34 | |
Ir | Information ratio | 0.02 |
ENDRA Life Volatility Alert
ENDRA Life Sciences exhibits above-average semi-deviation for your current time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure ENDRA Life's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact ENDRA Life's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.ENDRA Life Fundamentals Vs Peers
Comparing ENDRA Life's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ENDRA Life's direct or indirect competition across all of the common fundamentals between ENDRA Life and the related equities. This way, we can detect undervalued stocks with similar characteristics as ENDRA Life or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ENDRA Life's fundamental indicators could also be used in its relative valuation, which is a method of valuing ENDRA Life by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare ENDRA Life to competition |
| Fundamentals | ENDRA Life | Peer Average |
| Return On Equity | -1.49 | -0.31 |
| Return On Asset | -0.62 | -0.14 |
| Current Valuation | (1.99 M) | 16.62 B |
| Shares Outstanding | 536.91 K | 571.82 M |
| Shares Owned By Insiders | 0.27 % | 10.09 % |
| Shares Owned By Institutions | 0.02 % | 39.21 % |
| Number Of Shares Shorted | 33.2 K | 4.71 M |
| Price To Earning | (0.93) X | 28.72 X |
| Price To Book | 0.38 X | 9.51 X |
| EBITDA | (9.78 M) | 3.9 B |
| Net Income | (10.06 M) | 570.98 M |
| Cash And Equivalents | 11.28 M | 2.7 B |
| Cash Per Share | 0.18 X | 5.01 X |
| Total Debt | 394.4 K | 5.32 B |
| Debt To Equity | 0.05 % | 48.70 % |
| Current Ratio | 9.64 X | 2.16 X |
| Book Value Per Share | 12.35 X | 1.93 K |
| Cash Flow From Operations | (9.55 M) | 971.22 M |
| Short Ratio | 1.45 X | 4.00 X |
| Earnings Per Share | (106.69) X | 3.12 X |
| Target Price | 2625.0 | |
| Number Of Employees | 21 | 18.84 K |
| Beta | 0.5 | -0.15 |
| Market Capitalization | 2.52 M | 19.03 B |
| Total Asset | 6.75 M | 29.47 B |
| Retained Earnings | (91.93 M) | 9.33 B |
| Working Capital | 2.13 M | 1.48 B |
| Current Asset | 1.27 M | 9.34 B |
| Current Liabilities | 619.6 K | 7.9 B |
| Net Asset | 6.75 M |
Note: Disposition of tradable shares by Francois Michelon of ENDRA Life at 0.87 subject to Rule 16b-3 [view details]
ENDRA Life Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ENDRA . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About ENDRA Life Buy or Sell Advice
When is the right time to buy or sell ENDRA Life Sciences? Buying financial instruments such as ENDRA Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having ENDRA Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Munis Funds Thematic Idea Now
Munis Funds
Funds or Etfs that invest in fixed income securities issued by states, cities, and towns as well as other public entities. The Munis Funds theme has 42 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Munis Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out ENDRA Life Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ENDRA Life. If investors know ENDRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ENDRA Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ENDRA Life Sciences is measured differently than its book value, which is the value of ENDRA that is recorded on the company's balance sheet. Investors also form their own opinion of ENDRA Life's value that differs from its market value or its book value, called intrinsic value, which is ENDRA Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ENDRA Life's market value can be influenced by many factors that don't directly affect ENDRA Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ENDRA Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ENDRA Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ENDRA Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.